Demant A/S/€DEMANT
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Demant A/S
Demant A/S is a company specializing in hearing healthcare solutions. It operates in the medical technology industry, providing hearing aids, audiometric equipment, and hearing implants. The company also offers personal communication solutions and hearing care services through its retail network. Founded in 1904 and headquartered in Smørum, Denmark, Demant has a significant presence in Europe, North America, and other regions, serving users worldwide. The company's strategic positioning is strengthened by its focus on R&D and innovation, which supports its diverse product portfolio and ability to meet various customer needs in the hearing health market.
Ticker
€DEMANT
Sector
Primary listing
XGAT
Employees
22,057
Headquarters
Smørum, Denmark
Website
Demant A/S Metrics
BasicAdvanced
€7B
22.67
€1.45
0.90
-
Price and volume
Market cap
€7B
Beta
0.9
52-week high
€39.46
52-week low
€27.08
Average daily volume
100K
Financial strength
Current ratio
1.761
Quick ratio
0.96
Long term debt to equity
161.14
Total debt to equity
170.755
Interest coverage (TTM)
6.69%
Profitability
EBITDA (TTM)
656.703
Gross margin (TTM)
75.83%
Net profit margin (TTM)
10.21%
Operating margin (TTM)
18.48%
Effective tax rate (TTM)
21.48%
Revenue per employee (TTM)
€136,650
Management effectiveness
Return on assets (TTM)
8.02%
Return on equity (TTM)
28.09%
Valuation
Price to earnings (TTM)
22.672
Price to revenue (TTM)
2.314
Price to book
5.51
Price to tangible book (TTM)
-9.65
Price to free cash flow (TTM)
14.651
Free cash flow yield (TTM)
6.83%
Free cash flow per share (TTM)
2.24
Growth
Revenue change (TTM)
2.69%
Earnings per share change (TTM)
-1.01%
3-year revenue growth (CAGR)
6.58%
10-year revenue growth (CAGR)
8.65%
3-year earnings per share growth (CAGR)
1.33%
10-year earnings per share growth (CAGR)
8.02%
Bulls say / Bears say
The €700 million acquisition of Germany’s Kind Group will boost Demant’s market share in its largest European market from 4% to 12%, positioning it as Germany’s hearing care leader on the back of a bridge loan financed at below-average interest rates (Reuters)
Following the Kind deal, BNP Paribas Exane upgraded Demant’s rating to “outperform,” while Citi deemed the acquisition “strategically sensible,” signalling strong analyst conviction in Demant’s turnaround plan (Reuters)
Benchmark research firm Bernstein raised its rating on Demant to “outperform” and lifted its price target to DKK 338, citing the Kind acquisition, the return to the U.S. managed-care channel, and an expected new product launch within 12 months (Investing.com)
Shares in Demant fell 4% after management cut its full-year outlook, revising organic revenue growth to 1%–5% from 3%–7% and lowering its adjusted EBIT margin forecast to 18.1%–19.1% from 18.9%–19.9% (Reuters)
Shares dropped 5.6% as Demant’s cautious 2025 margin outlook—projecting an 18.9%–19.9% EBIT margin—and the lack of any new product launches disappointed investors (Reuters)
Management warned of an adverse DKK 125 million impact on 2025 EBIT from exchange rate developments, underscoring significant currency risks to profitability (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Demant A/S stock?
Demant A/S (DEMANT) has a market cap of €7B as of September 16, 2025.
What is the P/E ratio for Demant A/S stock?
The price to earnings (P/E) ratio for Demant A/S (DEMANT) stock is 22.67 as of September 16, 2025.
Does Demant A/S stock pay dividends?
No, Demant A/S (DEMANT) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Demant A/S dividend payment date?
Demant A/S (DEMANT) stock does not pay dividends to its shareholders.
What is the beta indicator for Demant A/S?
Demant A/S (DEMANT) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.